Related Experiment Video
Updated: Jul 16, 2025

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations
Published on: October 20, 2017
Onyx cast thrombectomy: bailout during thalamic AVM embolization.
Marco Colasurdo1,2, Huanwen Chen3,4, Gautam Edhayan5
1Neuroradiology, The University of Texas Medical Branch at Galveston, Galveston, Texas, USA.
Endovascular embolization of brain arteriovenous malformations (AVMs) can cause complications. A novel technique using stent-retriever and aspiration successfully retrieved migrated Onyx, preventing ischemic events during AVM treatment.
Area of Science:
- Neurology
- Neurosurgery
- Interventional Radiology
Background:
- Cerebral arteriovenous malformations (AVMs) are treated with microsurgical resection, radiosurgery, or endovascular embolization.
- Endovascular embolization, while effective, carries risks including hemorrhage and ischemic events from embolic migration or vessel occlusion.
Purpose of the Study:
- To present a case of Onyx embolization for a ruptured thalamic AVM.
- To demonstrate a novel bailout technique for managing Onyx reflux into the parent artery.
Main Methods:
- Endovascular embolization of a ruptured thalamic AVM using Onyx.
- Management of Onyx reflux into the posterior cerebral artery using a combined stent-retriever and aspiration catheter technique.
Main Results:
- Onyx reflux into the posterior cerebral artery occurred, causing complete vascular occlusion.
- The bailout technique successfully dislodged and retrieved the Onyx cast.
- Total occlusion of the targeted AVM feeder was maintained.
Conclusions:
- Endovascular treatment of AVMs can be complicated by embolic material migration.
- A combined stent-retriever and aspiration technique is an effective bailout strategy for managing Onyx reflux.
- This technique can prevent ischemic complications during AVM embolization.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins

